Advertisement
Advertisement

CRNX

CRNX logo

Crinetics Pharmaceuticals, Inc.

28.33
USD
-0.26
-0.91%
Aug 01, 09:31 UTC -4
Open

Crinetics Pharmaceuticals, Inc. Profile

About

CRINETICS PHARMACEUTICALS is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. CRINETICS PHARMACEUTICALS is based in SAN DIEGO.

Info & Links

CEO

R. Scott Struthers

Headquarters

6055 Lusk Boulevard
San Diego, CA 92121, UNITED STATES

Sector

Medical

Auditor

BDO USA, P.C.

Share holders

10

Employees

437

Crinetics Pharmaceuticals, Inc. Statistics

Valuation Measures

Market Capitalization2

2.65B

Enterprise Value

2.56B

Enterprise Value/EBITDA(ttm)

-6.58

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.19

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-11341.84%

Return on Equity(ttm)

-30.95%

Return on Invested Capital(ttm)

-31.94%

Return on Assets(ttm)

-28.12%

Income Statement

Revenue(ttm)

760.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

760.00K

EBITDA(ttm)3

-388.95M

Net Income Available to Common(ttm)

-328.25M

Diluted EPS(ttm)

-3.82

Share Statistics

Beta (5Y Monthly)

0.25

52-Week Change

-46.67%

S&P 500 52-Week Change

16.39%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

93.68M

Dividend Yield

0.00%

Float4

89.32M

% Held by Insiders

4.60%

% Held by Institutions

98.51%

Balance Sheet

Total Cash(mrq)

1.27B

Total Cash Per Share(mrq)

13.61

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

22.53%

Quick Ratio(mrq)

22.53%

Book Value Per Share(mrq)

13.41

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.95

Free Cash Flow(ytd)

-89.69M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement